Lactobacillus rhamnosus dampens cytokine and chemokine secretion from primary human nasal epithelial cells infected with rhinovirus
Journal of Applied Microbiology · 2024
DOI: 10.1093/jambio/lxae018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Microbiology, 2024. Verfasst von Tejasri Yarlagadda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Immunology and Infection Control, Queensland University of Technology, Brisbane 4000, Australia. Hauptthemen laut MEDLINE: Lacticaseibacillus rhamnosus, Enterovirus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Children's Hospital Foundation.
Abstract (Originalsprache)
Aims
To investigate the effect of Lactobacillus rhamnosus on viral replication and cellular response to human rhinovirus (HRV) infection, including the secretion of antiviral and inflammatory mediators from well-differentiated nasal epithelial cells (WD-NECs). Methods and results The WD-NECs from healthy adult donors (N = 6) were cultured in vitro, exposed to different strains of L. rhamnosus (D3189, D3160, or LB21), and infected with HRV (RV-A16) after 24 h. Survival and adherence capacity of L. rhamnosus in a NEC environment were confirmed using CFSE-labelled isolates, immunofluorescent staining, and confocal microscopy. Shed virus and viral replication were quantified using TCID50 assays and RT-qPCR, respectively. Cytotoxicity was measured by lactate dehydrogenase (LDH) activity. Pro-inflammatory mediators were measured by multiplex immunoassay, and interferon (IFN)-λ1/3 was measured using a standard ELISA kit. Lactobacillus rhamnosus was able to adhere to and colonize WD-NECs prior to the RV-A16 infection. Lactobacillus rhamnosus did not affect shed RV-A16, viral replication, RV-A16-induced IFN-λ1/3 production, or LDH release. Pre-exposure to L. rhamnosus, particularly D3189, reduced the secretion of RV-A16-induced pro-inflammatory mediators by WD-NECs.
Conclusions
These findings demonstrate that L. rhamnosus differentially modulates RV-A16-induced innate inflammatory immune responses in primary NECs from healthy adults.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Immunology and Infection Control, Queensland University of Technology, Brisbane 4000, Australia.
- School of Chemistry and Molecular Biosciences, University of Queensland, St Lucia 4072, Australia.
- University of Queensland Frazer Institute, Woolloongabba 4102, Australia.
- Faculty of Medicine, University of Queensland Centre for Clinical Research, Herston 4006, Australia.
Förderung
- Children's Hospital Foundation
Zitieren
APA
Yarlagadda, T., Zhu, Y., Snape, N., Carey, A., Bryan, E., Maresco-Pennisi, D., Coleman, A., Cervin, A., & Spann, K. (2024). Lactobacillus rhamnosus dampens cytokine and chemokine secretion from primary human nasal epithelial cells infected with rhinovirus. Journal of Applied Microbiology. https://doi.org/10.1093/jambio/lxae018
Vancouver
Yarlagadda T, Zhu Y, Snape N, Carey A, Bryan E, Maresco-Pennisi D, et al. Lactobacillus rhamnosus dampens cytokine and chemokine secretion from primary human nasal epithelial cells infected with rhinovirus. Journal of Applied Microbiology. 2024. doi:10.1093/jambio/lxae018
BibTeX
@article{Yarlagadda2024,
author = {Yarlagadda, Tejasri and Zhu, Yanshan and Snape, Natale and Carey, Alison and Bryan, Emily and Maresco-Pennisi, Diane and Coleman, Andrea and Cervin, Anders and Spann, Kirsten},
title = {Lactobacillus rhamnosus dampens cytokine and chemokine secretion from primary human nasal epithelial cells infected with rhinovirus},
journal = {Journal of Applied Microbiology},
year = {2024},
doi = {10.1093/jambio/lxae018}
}
EUVIMED